Clariant

Clariant’s new VAMax™ catalysts improve the economics of the Vinyl-Acetate Monomer production process

  • Vinyl-Acetate Monomer (VAM) is a key component for polymer and co-polymer derivatives
  • Clariant’s new, high activity VAMax™-series of catalysts have proven commercially effective
  • VAMax catalysts can help high volume producers increase yields using existing production equipment

Munich, August 25, 2015 – Clariant, a world leader in specialty chemicals, announced today the successful expansion of its selective oxidation catalyst portfolio with its new VAMax™ -series catalysts, which offers high-activity for Vinyl-Acetate Monomer (VAM) producers.

VAM is produced by reacting ethylene and acetic acid with oxygen in the presence of a catalyst. It is an essential building block for various polymer and co-polymer derivatives, which find broad applications in the manufacture of paints, adhesives and performance plastics for the automotive and construction industries. Global VAM consumption is expected to reach nearly 8-million tons by 2020, growing at a CAGR of +4.4%*.

Clariant’s VAMax series of catalysts have demonstrated consistent and outstanding performance in commercial scale production of VAM over extended run-lengths. An attractive aspect of VAMax is its high activity characteristic. This can allow a VAM producer seeking to increase production to achieve higher yields on the basis of the same scale of production equipment. In consequence, this makes new plant projects more attractive by helping reduce the specific investment amount required per metric tonne of VAM capacity. Clariant’s high activity catalysts can further be a viable option for de-bottlenecking existing VAM plants, as well.

Catalysts within the VAMax series can be matched to meet the specific requirements of diverse VAM plants. Because of this, Clariant can work with VAM producers to find the most suitable catalyst solution depending upon their economic and technical needs.

Stefan Heuser, Senior Vice President & General Manager BU Catalysts, Clariant, stated: “Our new VAMax product line gives our VAM producing customers new options to increase production without added infrastructure expense.”

*Grand View Research, "Global Vinyl Acetate Monomer (VAM) Market Analysis And Segment Forecasts To 2020," January 2015

Reader enquiries

Clariant International Ltd
Rothausstrasse 61
4132 Muttenz 1
Switzerland

+41 61 469 6742

www.clariant.com

@clariant

Clariant

ClariantInternational

clariant_international


Notes for editors


™ FILED TRADEMARK APPLICATION

www.clariant.com

Clariant is a globally leading specialty chemicals company, based in Muttenz near Basel/Switzerland. On December 31, 2014 the company employed a total workforce of 17 003. In the financial year 2014, Clariant recorded sales of CHF 6.116 billion for its continuing businesses. The company reports in four business areas: Care Chemicals, Catalysis & Energy, Natural Resources, and Plastics & Coatings. Clariant’s corporate strategy is based on five pillars: increase profitability, reposition portfolio, add value with sustainability, foster innovation and R&D, and intensify growth.

www.clariant.com/catalysts

Clariant’s Catalysts Unit is a leading global developer and producer of catalysts for industrial processes since the acquisition of Süd-Chemie in 2011. With a total of 18 production sites, 14 sales offices, and 12 R&D and technical centers it is headquartered in Munich, Germany. Approximately 1790 employees serve customers around the world. Aimed at delivering sustainable value to customers, Clariant’s catalysts and adsorbents are designed to increase production throughput, lower energy consumption, and reduce hazardous emissions from industrial processes. The broad portfolio also includes products that enable the use of alternative feedstock for chemical and fuel production.

 

Editorial enquiries

Carsten Seum
Clariant International Ltd

+41 61 469 63 63

carsten.seum@​clariant.com

Stefanie Nehlsen
Clariant International Ltd

+41 61 469 63 63

stefanie.nehlsen@​clariant.com

Josina van der Velden
EMG

+31 164 317 014

jvandervelden@​emg-marcom.com

 

Share

 

More news from